Akari Therapeutics Plc
ID: 5312926Akari Therapeutics Plc is a novel anti-inflammatory, first-in-class synthetic drugs founded in 2015.
3
Funding Rounds
$34.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| ra****** ja***** | - | - |
Funding series
Funding Series Analysis
The company Akari Therapeutics Plc has raised a total of $12.5m in funding over 3 rounds.
Key Insights:
- Akari Therapeutics Plc funding round, October 2013: $12.5m
- Akari Therapeutics Plc funding round, March 2020: $9.55m
- Akari Therapeutics Plc funding round, July 2021: $12.32m
Industries
Akari Therapeutics Plc is active in the following industries: